William Blair Investment Management LLC acquired a new stake in shares of Hawkins, Inc. (NASDAQ:HWKN – Free Report) during the fourth quarter, HoldingsChannel reports. The fund acquired 134,439 shares of the specialty chemicals company’s stock, valued at approximately $19,098,000.
A number of other hedge funds have also added to or reduced their stakes in HWKN. Capital World Investors increased its position in Hawkins by 618.8% during the 3rd quarter. Capital World Investors now owns 355,619 shares of the specialty chemicals company’s stock valued at $64,979,000 after purchasing an additional 306,143 shares during the period. Invesco Ltd. increased its position in Hawkins by 44.4% during the 3rd quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company’s stock valued at $74,512,000 after purchasing an additional 125,444 shares during the period. Granite Investment Partners LLC purchased a new position in Hawkins during the 3rd quarter valued at $11,610,000. Vanguard Group Inc. increased its position in Hawkins by 2.8% during the 3rd quarter. Vanguard Group Inc. now owns 1,504,831 shares of the specialty chemicals company’s stock valued at $274,963,000 after purchasing an additional 41,652 shares during the period. Finally, Wasatch Advisors LP increased its position in Hawkins by 10.9% during the 3rd quarter. Wasatch Advisors LP now owns 420,569 shares of the specialty chemicals company’s stock valued at $76,846,000 after purchasing an additional 41,184 shares during the period. 69.71% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on HWKN shares. BWS Financial reissued a “buy” rating and set a $200.00 price objective on shares of Hawkins in a research report on Monday, March 23rd. Weiss Ratings raised shares of Hawkins from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, May 14th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Hawkins presently has a consensus rating of “Moderate Buy” and an average price target of $200.00.
Hawkins Price Performance
NASDAQ:HWKN opened at $153.14 on Tuesday. The firm’s 50-day moving average price is $154.56 and its 200-day moving average price is $146.34. The company has a market capitalization of $3.20 billion, a PE ratio of 39.17, a P/E/G ratio of 2.76 and a beta of 0.81. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.21 and a quick ratio of 1.46. Hawkins, Inc. has a 1-year low of $117.98 and a 1-year high of $186.15.
Hawkins (NASDAQ:HWKN – Get Free Report) last released its earnings results on Wednesday, May 13th. The specialty chemicals company reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The business had revenue of $265.91 million during the quarter, compared to analysts’ expectations of $255.28 million. Hawkins had a return on equity of 16.08% and a net margin of 7.53%. On average, equities analysts predict that Hawkins, Inc. will post 4.27 EPS for the current fiscal year.
Hawkins Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Friday, May 29th will be given a $0.19 dividend. The ex-dividend date of this dividend is Friday, May 29th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.5%. Hawkins’s dividend payout ratio is currently 19.44%.
About Hawkins
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
See Also
- Five stocks we like better than Hawkins
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKN – Free Report).
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
